157 related articles for article (PubMed ID: 15104372)
1. Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C.
Ohata K; Yano K; Yatsuhashi H; Daikoku M; Koga M; Eguchi K; Yano M
Dig Dis Sci; 2004 Feb; 49(2):289-94. PubMed ID: 15104372
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
Dill MT; Makowska Z; Duong FHT; Merkofer F; Filipowicz M; Baumert TF; Tornillo L; Terracciano L; Heim MH
Gastroenterology; 2012 Sep; 143(3):777-786.e6. PubMed ID: 22677194
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study.
Fujiwara D; Hino K; Yamaguchi Y; Kubo Y; Yamashita S; Uchida K; Konishi T; Nakamura H; Korenaga M; Okuda M; Okita K
J Viral Hepat; 2004 Mar; 11(2):136-40. PubMed ID: 14996348
[TBL] [Abstract][Full Text] [Related]
4. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection.
Morita K; Tanaka K; Saito S; Kitamura T; Kondo M; Sakaguchi T; Morimoto M; Sekihara H
J Clin Gastroenterol; 1998 Mar; 26(2):135-40. PubMed ID: 9563926
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.
De Rosa FG; Bargiacchi O; Audagnotto S; Garazzino S; Cariti G; Raiteri R; Di Perri G
J Antimicrob Chemother; 2006 Feb; 57(2):360-3. PubMed ID: 16396921
[TBL] [Abstract][Full Text] [Related]
6. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
7. Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.
Lee CM; Kee KM; Hung CH; Eng HL; Chang CH; Huang CM; Wang JH; Hu TH; Lu SN; Changchien CS; Chen WJ
Antivir Ther; 2006; 11(1):17-23. PubMed ID: 16518956
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update.
Thévenot T; Regimbeau C; Ratziu V; Leroy V; Opolon P; Poynard T
J Viral Hepat; 2001 Jan; 8(1):48-62. PubMed ID: 11155152
[TBL] [Abstract][Full Text] [Related]
9. Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus-related chronic liver disease.
Meng XW; Chi BR; Chen LG; Zhang LL; Zhuang Y; Huang HY; Sun X
World J Gastroenterol; 2005 Jul; 11(25):3962-5. PubMed ID: 15991303
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Rizzo G; Barbarini G
Am J Gastroenterol; 1998 Dec; 93(12):2445-51. PubMed ID: 9860407
[TBL] [Abstract][Full Text] [Related]
12. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C.
Yatsuhashi H; Fujino T; Matsumoto T; Inoue O; Koga M; Yano M
J Hepatol; 1999 Jun; 30(6):995-1003. PubMed ID: 10406176
[TBL] [Abstract][Full Text] [Related]
16. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver.
Fukuda R; Ishimura N; Hamamoto S; Moritani M; Uchida Y; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
J Med Virol; 2001 Mar; 63(3):220-7. PubMed ID: 11170061
[TBL] [Abstract][Full Text] [Related]
17. Association of SNPs in interferon receptor genes in chronic hepatitis C with response to combined therapy of interferon and ribavirin.
Heidari Z; Shahzamani K; Ghanbari R; Tahamsebifar A
Acta Med Iran; 2014; 52(10):740-7. PubMed ID: 25369007
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
[TBL] [Abstract][Full Text] [Related]
19. Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy.
Fukuda R; Ishimura N; Ishihara S; Tokuda A; Satoh S; Sakai S; Akagi S; Watanabe M; Fukumoto S
J Gastroenterol; 1996 Dec; 31(6):806-11. PubMed ID: 9027643
[TBL] [Abstract][Full Text] [Related]
20. Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial.
Gaeta GB; Di Virgilio D; Russo G; Stornaiuolo G; Nicolella U; Colella F; Grimaldi M; Pasquale G; Giusti G
J Viral Hepat; 1997 May; 4(3):209-14. PubMed ID: 9181530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
